In this study, we found that mepolizumab treatment in severe uncontrolled asthma was very effective, significantly reducing OCS bursts per year, maintenance OCS, blood eosinophil levels, IgE, and annual rate of exacerbations requiring emergency department treatment and/or hospitalization. The gene discussed is IGHE; the disease is asthma.